BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34865224)

  • 1. Efficacy and safety of laser-assisted combination chemotherapy: A follow-up study of treatment with 5-fluorouracil and cisplatin for basal cell carcinoma.
    Fredman G; Wenande E; Hendel K; Togsverd-Bo K; Haedersdal M
    Lasers Surg Med; 2022 Jan; 54(1):113-120. PubMed ID: 34865224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Laser-Assisted Combination Chemotherapy: An Explorative Imaging-Guided Treatment With 5-Fluorouracil and Cisplatin for Basal Cell Carcinoma.
    Wenande E; Hendel K; Mogensen M; Bagger C; Mårtensson NL; Persson DP; Lerche CM; Husted S; Janfelt C; Togsverd-Bo K; Anderson RR; Haedersdal M
    Lasers Surg Med; 2021 Jan; 53(1):119-128. PubMed ID: 32960987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography-guided Nd:YAG laser treatment and follow-up of basal cell carcinoma.
    Kranz S; Brunnmeier G; Yilmaz P; Thamm J; Schiele S; Müller G; Key C; Welzel J; Schuh S
    Lasers Surg Med; 2023 Mar; 55(3):257-267. PubMed ID: 36740365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinoma treated with combined ablative fractional laser and ingenol mebutate - an exploratory study monitored by optical coherence tomography and reflectance confocal microscopy.
    Banzhaf CA; Phothong W; Suku MH; Ulrich M; Philipsen PA; Mogensen M; Haedersdal M
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):502-509. PubMed ID: 31442334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
    Hsu SH; Gan SD; Nguyen BT; Konnikov N; Liang CA
    Dermatol Surg; 2016 Sep; 42(9):1050-3. PubMed ID: 27359199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial.
    Choi SH; Kim KH; Song KH
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):783-8. PubMed ID: 26551044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin.
    Wenande E; Tam J; Bhayana B; Schlosser SK; Ishak E; Farinelli WA; Chlopik A; Hoang MP; Pinkhasov OR; Caravan P; Rox Anderson R; Haedersdal M
    J Control Release; 2018 Apr; 275():242-253. PubMed ID: 29454062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
    Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local vasoregulative interventions impact drug concentrations in the skin after topical laser-assisted delivery.
    Wenande E; Gundavarapu SC; Tam J; Bhayana B; Thomas CN; Farinelli WA; Vakoc BJ; Anderson RR; Haedersdal M
    Lasers Surg Med; 2022 Dec; 54(10):1288-1297. PubMed ID: 35593006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Carbon Dioxide Laser with Photodynamic Therapy for Nodular Basal Cell Carcinoma Monitored by Reflectance Confocal Microscopy.
    Alma A; Pongetti L; Clementi A; Chester J; Toccaceli M; Ciardo S; Zappia E; Manfredini M; Pellacani G; Greco M; Bennardo L; Farnetani F
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256291
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.
    Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O
    Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma.
    Shokrollahi K; Javed M; Aeuyung K; Ghattaura A; Whitaker IS; O'Leary B; James W; Murison M
    Ann Plast Surg; 2014 Nov; 73(5):552-8. PubMed ID: 23407256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Love WE; Bernhard JD; Bordeaux JS
    Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
    J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial.
    Brinkhuizen T; Frencken KJ; Nelemans PJ; Hoff ML; Kelleners-Smeets NW; Zur Hausen A; van der Horst MP; Rennspiess D; Winnepenninckx VJ; van Steensel MA; Mosterd K
    J Am Acad Dermatol; 2016 Jul; 75(1):126-34. PubMed ID: 27067393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
    Naik MP; Mehta A; Abrol S; Kumar S; Gupta VS
    Orbit; 2016 Dec; 35(6):352-354. PubMed ID: 27715359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study.
    Christensen E; Mørk C; Skogvoll E
    Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
    Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
    Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.